Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1
Public ClinicalTrials.gov record NCT02707861. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Expanded Access Study of Ibalizumab Plus an Optimized Background Regimen (OBR) in Treatment-Experienced Patients Infected With Multi-Drug Resistant (MDR) HIV-1
Study identification
- NCT ID
- NCT02707861
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- TaiMed Biologics Inc.
- Industry
- Enrollment
- 79 participants
Conditions and interventions
Conditions
Interventions
- ibalizumab Drug
- Optimized Background Regimen Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2016
- Primary completion
- Oct 31, 2018
- Completion
- Oct 31, 2018
- Last update posted
- Mar 10, 2021
2016 – 2018
United States locations
- U.S. sites
- 31
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Long Beach Education and Research Consultants | Long Beach | California | 90813 | — |
| Southern California Permanente Medical Group | Los Angeles | California | 90027 | — |
| Ruane Clinical Research Institute Inc. | Los Angeles | California | 90036 | — |
| Charles R. Drew University of Medicine and Science, Clinical and Translational Research Center | Los Angeles | California | 90059 | — |
| Anthony Mills MD Inc. | Los Angeles | California | 90069 | — |
| Palmtree Clinical Research, Inc. | Palm Springs | California | 92262 | — |
| eStudy Site | San Francisco | California | 94115 | — |
| Kaiser Foundation Research Institute | San Francisco | California | 94118 | — |
| Yale University | New Haven | Connecticut | 06510 | — |
| Georgetown University School of Medicine | Washington D.C. | District of Columbia | 20007 | — |
| Gary Richmond, MD, PA | Fort Lauderdale | Florida | 33316 | — |
| AIDS Healthcare Foundation - Kinder Medical Group | Miami | Florida | 33133 | — |
| AIDS Healthcare Foundation - South Beach | Miami | Florida | 33140 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| Triple O Research Institute | West Palm Beach | Florida | 33401 | — |
| AIDS Research Consortium of Atlanta | Atlanta | Georgia | 30312 | — |
| University of Hawaii - John A. Burns School of Medicine | Honolulu | Hawaii | 96813 | — |
| Howard Brown Health Center | Chicago | Illinois | 60613 | — |
| National Institute of Allergy & Infectious Diseases | Bethesda | Maryland | 20892 | — |
| ID Research Institute | Springfield | Massachusetts | 01105 | — |
| Central West Clinical Research | St Louis | Missouri | 63108 | — |
| AIDS Healthcare Foundation - Manhattan Midtown HCC | New York | New York | 10001 | — |
| Chelsea Village Medical | New York | New York | 10011 | — |
| Jacobi Medical Center | The Bronx | New York | 10461 | — |
| East Carolina University | Greenville | North Carolina | 27834 | — |
| Philadelphia FIGHT | Philadelphia | Pennsylvania | 19107 | — |
| St. Jude's Children's Research Hospital | Memphis | Tennessee | 38105 | — |
| St. Hope Foundation Community Health Center | Bellaire | Texas | 77401 | — |
| North Texas Infectious Disease Consultants | Dallas | Texas | 75246 | — |
| Crofoot Research Center | Houston | Texas | 77098 | — |
| Research Access Network | Houston | Texas | 77098 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02707861, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 10, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02707861 live on ClinicalTrials.gov.